Brief: Evaxion Biotech Q2 Basic EPS USD -0.02
14/08/2025 12:31
Aug 14 (Reuters) - Evaxion Biotech Q2 net income USD -4.831 million. Q2 operating income USD -4.34 million Q2 pretax profit USD -5.026 million
Recent news on Evaxion A/S
See all newsEvaxion A/S reports results for the quarter ended June 30 - Earnings Summary
Denmark's Evaxion Q2 net loss narrows on lower expenses
Brief: Evaxion Q2 Basic EPS USD -0.01
Evaxion A/S expected to post a loss of 31 cents a share - Earnings Preview
Brief: Evaxion A/S - Expands Pipeline Of Cancer Vaccine Programs With Evx-05 Against Brain Cancer Glioblastoma